Skip to main content
Internal Medicine logoLink to Internal Medicine
. 2017 Oct 11;57(1):135–139. doi: 10.2169/internalmedicine.9247-17

Disseminated Cryptococcosis with Marked Eosinophilia in a Postpartum Woman

Tetsuya Yokoyama 1, Masako Kadowaki 1, Makoto Yoshida 1, Kunihiro Suzuki 1, Masashi Komori 1, Tomoaki Iwanaga 1
PMCID: PMC5799072  PMID: 29021482

Abstract

Disseminated cryptococcosis usually develops in immunosuppressed patients. A 33-year-old postpartum woman developed disseminated cryptococcosis with marked eosinophilia. She presented with a cough and a week-long fever. A computed tomography scan showed multiple pulmonary nodules randomly distributed. Eosinophils were observed to have increased in number in both her peripheral blood and bronchoalveolar lavage fluid. A transbronchial lung biopsy and cerebrospinal fluid specimens revealed findings consistent with cryptococcal infection. Disseminated cryptococcosis can present with marked eosinophilia of the peripheral blood and lung tissues. Additionally, the postpartum immune status may sometimes be involved in the development of opportunistic infections in previously healthy women.

Keywords: Cryptococcus neoformans, eosinophilia, immune reconstitution inflammatory syndrome, postpartum period

Introduction

Cryptococcosis usually manifests as localized infections of the lung or skin - sometimes of the central nervous system in a disseminated form - usually in immunosuppressed hosts. Peripheral blood and pulmonary eosinophilia associated with cryptococcosis is an uncommon manifestation. Additionally, the occurrence of cryptococcosis during the postpartum period suggests instability of the immune system. We herein report a case of disseminated cryptococcosis with marked eosinophilia in a postpartum woman.

Case Report

A healthy 33-year-old woman, who had delivered a child five months earlier, visited a clinic with a cough, wheezing, and a week-long fever. As she had hypereosinophilia in her peripheral blood and a computed tomography (CT) scan indicated multiple pulmonary nodules, she was admitted to our hospital for further evaluation. She did not look critically ill and had neither any appreciable disease, atopic disposition, or history of animal exposure. Her heart and respiratory sounds were normal. The superficial lymph nodes were not palpable. Cutaneous involvement was not identified. A blood examination revealed significant eosinophilia (17,887 cells/mm3) and a modest elevation of C-reactive protein (Table 1). Chest X-rays showed multiple nodular opacities in the bilateral lung fields. Chest CT showed diffuse and randomly distributed small pulmonary nodules (Figure a and b).

Table 1.

Laboratory Findings on Admission.

White blood cells 26,500 cells/mm3 Blood urea nitrogen 7 mg/dL
Neutrophils 21.0 % Creatinine 0.58 mg/dL
Lymphocytes 11.0 % Uric acid 4.7 mg/dL
Eosinophils 67.5 % Sodium 142 mEq/L
Hemoglobin 12.5 g/dL Potassium 4.1 mEq/L
Platelets 21.9×104 cells/mm3 Chloride 106 mEq/L
Total protein 7.2 g/dL Calcium 9.2 mg/dL
Albumin 3.6 g/dL Glucose 85 mg/dL
Total bilirubin 0.5 mg/dL Hemoglobin A1c 5.1 %
Aspartate aminotransferase 10 IU/L C-reactive protein 1.15 mg/dL
Alanine aminotransferase 12 IU/L Immunoglobulin G 1,683 mg/dL
Lactate dehydrogenase 247 IU/L Immunoglobulin A 232 mg/dL
Alkaline phosphatase 329 IU/L Immunoglobulin M 176 mg/dL
γ-glutamyl transpeptidase 11 IU/L Immunoglobulin E 1,943 IU/mL
Creatine kinase 40 IU/L

Figure.

Figure.

(a, b) Chest computed tomography images show many small pulmonary nodules and a few bilateral pleural effusions. The nodules are randomly distributed and on the pleura (white arrow), which suggests that they are distributed with a hematogenous spread. Cryptococcus sp. is detected from cerebrospinal fluid and lung tissue specimens. (c) A lung biopsy specimen shows many yeast-like cells. They are positive for Grocott’s silver stain. (d) India ink stain reveals capsules of yeast-like fungus bodies in cerebrospinal fluid specimens (magnification: ×1,000).

We performed bronchoscopy. The cell numbers in bronchoalveolar lavage (BAL) fluids were significantly increased (14.66×105 cells/mL) with a high proportion of eosinophils (89%). No evidence of Mycobacterium tuberculosis or any malignant neoplasms was found in the BAL fluids and transbronchial lung biopsy specimens, respectively. Biopsy specimens showed the aggregation of eosinophils within alveolar spaces, and Grocott's silver stain identified yeast-like fungus bodies (Figure c). A progressively worsening headache appeared after admission; therefore, we performed a lumbar puncture. A cerebrospinal fluid (CSF) analysis is shown in Table 2. The number of cells increased, with a predominance of eosinophils. India ink stain showed yeast-like fungus bodies in the CSF (Figure d). Cryptococcal antigen titers from serum and CSF were 1:8 and 1:256, respectively. Cryptococcus neoformans var. neoformans was then isolated from the CSF and urine. Finally, we diagnosed the patient to have disseminated cryptococcosis.

Table 2.

Cerebrospinal Fluid Analysis.

Opening pressure 46 cm H2O
Cell counts 84 cells/mm3
Neutrophils +/-
Lymphocytes 1+
Eosinophils 2+
Protein 32.3 mg/dL
Glucose 49 mg/dL

We confirmed that she was not immunosuppressed. Idiopathic CD4+ T lymphocytopenia was unlikely because her peripheral lymphocyte number was normal and the proportion of CD4+ cells was 52.1%. Anti-interferon-γ autoantibody-induced cellular immunodeficiency was excluded because no anti-interferon-γ autoantibodies were detected. In addition, human immunodeficiency virus (HIV) and human T-cell leukemia virus type 1 (HTLV-1) infection were negative.

An antifungal drug was started, but the patient was transferred to a highly specialized hospital to manage an acute episode of epileptic seizures and a disturbance of consciousness two days later. Fortunately, she recovered with subsequent antifungal treatment.

Discussion

We discovered two important clinical issues based on the findings of this rare case. First, disseminated cryptococcosis can present with marked eosinophilia of peripheral blood and lung tissues. Eosinophilia is uncommon in cryptococcal infection. Although the mechanism underlying eosinophilia has not yet been fully elucidated, some basic research reports an allergic reaction to C. neoformans. The intratracheal injection of C. neoformans induced inflammatory cells, including eosinophils, in rodents (1). A recent study demonstrated that a C. neoformans infection induced pulmonary IL-33 production with the accumulation of type 2 innate lymphoid cells (ILC2) in mice (2). ILC2 is a major source of IL-5, a potent inducer of eosinophils, in a murine asthma model (3). We reviewed previous case reports of cryptococcosis with eosinophilia in adolescents and adults (Table 3). The identified pathogens were all C. neoformans; eosinophilia was seen in not only disseminated cases, but also in localized infections. No HIV-positive patients were reported. The most notable finding is that all patients with eosinophilia recovered, which indicates that eosinophils might play a protective role in cryptococcosis. Rat eosinophils are reported to opsonize C. neoformans phagocytosis and present C. neoformans antigens to trigger a fungal-specific Th1 immune response (11); this indicates the advantage of eosinophilia for cryptococcal infection. A recent retrospective study about pediatric cryptococcosis showed that peripheral blood eosinophilia was seen in 7 of 23 cases, especially in 5 of 11 disseminated cases (12), which indicates that peripheral blood eosinophilia in cryptococcal disease is a more common manifestation than generally recognized.

Table 3.

Review of Cryptococcosis with Eosinophilia in Adolescents and Adults.

Age/Sex Eosinophil (cells/mm3) Site of infection Underlying disease Treatment Outcome Reference
23 M 42,559 Disseminated Sarcoidosis AMPH-B+5-FC+MCZ Recovered 4
16 F 10,500 Disseminated Nothing AMPH-B Recovered 5
64 F 3,400 Disseminated Unknown AMPH-B+5-FC+FLCZ Recovered 6
23 M 27,750 Disseminated Nothing AMPH-B+5-FC Recovered 7
22 F 16,811 Disseminated Nothing AMPH-B+5-FC Recovered 8
61 M 6,252 Lung Cancer FLCZ Recovered 9
28 M 6,000 Lung Nothing L-AMB+5-FC Recovered 10
33 F 17,887 Disseminated Nothing L-AMB+FLCZ Recovered Present case

M: male, F: female, AMPH-B: amphotericin B, 5-FC: flucytosine, MCZ: miconazole, FLCZ: fluconazole, L-AMB: liposomal amphotericin B

Second, the postpartum immune status may sometimes be involved in the development of opportunistic infections in previously healthy women. Cryptococcal infection is prone to develop during the postpartum period. We could not detect any evidence of immunosuppression in the present case except for her delivery five months earlier. Pregnancy causes a relatively immunosuppressed state for tolerating fetal antigens (13). The maternal immune system shifts from Th2 to Th1 after delivery, which can induce immune reconstitution inflammatory syndrome (IRIS) (13). IRIS is sometimes seen in immunosuppressed persons, which, paradoxically, worsens previously acquired asymptomatic and opportunistic infections during recovery of the host's immune system (14). Cryptococcal infection triggered by anti-retroviral therapy for HIV-positive patients is well documented (15). Although we could not identify precisely when the present case became infected, we speculate that she had been latently infected by C. neoformans before delivery, and the alteration of her immune status in the postpartum period subsequently activated the pathogen. A review of cryptococcosis in the postpartum period without HIV infection is shown in Table 4. The time of onset after delivery was mostly within the range of one week to half a year (median: two months). The pathogens were one case each of C. gattii and C. laurentii (18, 23), and the others were C. neoformans.

Table 4.

Review of Cryptococcosis in the Postpartum Period without HIV Infection.

Age Time after delivery Site of infection Underlying disease Treatment Outcome Reference
30 6 weeks Lung Nothing MCZ+FLCZ Recovered 16
28 3 weeks Lung Nothing FLCZ Recovered 17
18 5 days Disseminated Nothing AMPH-B+5-FC Recovered 18
29 4 months Lung Nothing FLCZ+5-FC Recovered 19
25 2 months Lung Nothing FLCZ Recovered 20
25 1 week Brain Nothing FLCZ Recovered 21
28 1 month Lung Nothing Resection Recovered 22
30 2 months Disseminated Nothing AMPH-B Dead 23
33 5 months Disseminated Nothing L-AMB+FLCZ Recovered Present case

MCZ: miconazole, FLCZ: fluconazole, AMPH-B: amphotericin B, 5-FC: flucytosine, L-AMB: liposomal amphotericin B

Marked eosinophilia with Th1 predominance could be inconsistent because Th2 cytokines induce eosinophil differentiation. Our patient developed cryptococcosis as late as five months after delivery, when the Th1 predominance might have been restored. In addition, excessive Th2 responses could be triggered by cryptococcal antigens while reconstituting immunity is unstable. Because disseminated C. neoformans infection is fairly uncommon in immunocompetent patients, we diagnosed the present case to have postpartum IRIS.

In conclusion, we herein reported a case presenting with disseminated cryptococcosis as postpartum IRIS with marked eosinophilia for the first time. This is a fairly rare case; however, it implies a protective role of eosinophilia and recognizes postpartum immune system instability. In future studies, it is necessary to elucidate the precise mechanism and function of eosinophil aggregation in response to cryptococcal infection, and the risk factors and precautions that need to be taken to prevent the onset of postpartum IRIS.

The authors state that they have no Conflict of Interest (COI).

Acknowledgement

We thank Dr. Hiroshi Iwasaki (Department of Pathology, Fukuoka University School of Medicine, Fukuoka, Japan) for pathological support, Dr. Takuro Sakagami (Department of Medicine (II), Niigata University Medical School, Niigata, Japan) for anti-IFN-γ autoantibody screening, and Dr. Keiji Nakamura and his colleagues (Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan) for performing the subsequent therapy.

References

  • 1. Goldman D, Lee SC, Casadevall A. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect Immun 62: 4755-4761, 1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Flaczyk A, Duerr CU, Shourian M, Lafferty EI, Fritz JH, Qureshi ST. IL-33 signaling regulates innate and adaptive immunity to Cryptococcus neoformans. J Immunol 191: 2503-2513, 2013. [DOI] [PubMed] [Google Scholar]
  • 3. Klein Wolterink RG, Kleinjan A, van Nimwegen M, et al. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur J Immunol 42: 1106-1116, 2012. [DOI] [PubMed] [Google Scholar]
  • 4. Tanaka H, Urase F, Hasegawa H, Tsubaki K, Irimajiri K, Horiuchi A. Sarcoidosis with severe eosinophilia due to cryptococcus infection. Rinsho Ketsueki (Jpn J Clin Hamatol) 29: 208-213, 1988(in Japanese). [PubMed] [Google Scholar]
  • 5. Memon SB, Memon AM, Faisal S, Kapadia N, Soomro IN. Cryptococcus-diversity of clinical presentation. J Pak Med Assoc 51: 337-339, 2001. [PubMed] [Google Scholar]
  • 6. Grosse P, Schulz J, Schmierer K. Diagnostic pitfalls in eosinophilic cryptococcal meningoencephalitis. Lancet Neurol 2: 512, 2003. [DOI] [PubMed] [Google Scholar]
  • 7. Yamaguchi H, Komase Y, Ikehara M, Yamamoto T, Shinagawa T. Disseminated cryptococcal infection with eosinophilia in a healthy person. J Infect Chemother 14: 319-324, 2008. [DOI] [PubMed] [Google Scholar]
  • 8. Pfeffer PE, Sen A, Das S, et al. Eosinophilia, meningitis and pulmonary nodules in a young woman. Thorax 65: 1066, 2010. [DOI] [PubMed] [Google Scholar]
  • 9. Kishida N, Okinaka K, Fujita T, Gu Y, Ohmagari N. Non disseminated pulmonary cryptococcosis with very marked eosinophilia in solid-organ cancer. Kansenshogaku Zasshi (J Jpn Assoc Infect Dis) 84: 597-601, 2010(in Japanese, Abstract in English). [DOI] [PubMed] [Google Scholar]
  • 10. Bassetti M, Mikulska M, Nicco E, Viscoli C. Pulmonary cryptococcosis with severe eosinophilia in an immunocompetent patient. J Chemother 22: 366-367, 2010. [DOI] [PubMed] [Google Scholar]
  • 11. Garro AP, Chiapello LS, Baronetti JL, Masih DT. Rat eosinophils stimulate the expansion of Cryptococcus neoformans-specific CD4(+) and CD8(+) T cells with a T-helper 1 profile. Immunology 132: 174-187, 2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Luo FL, Tao YH, Wang YM, Li H. Clinical study of 23 pediatric patients with cryptococcosis. Eur Rev Med Pharmacol Sci 19: 3801-3810, 2015. [PubMed] [Google Scholar]
  • 13. Singh N, Perfect JR. Immune reconstitution syndrome and exacerbation of infections after pregnancy. Clin Infect Dis 45: 1192-1199, 2007. [DOI] [PubMed] [Google Scholar]
  • 14. Shelburne SA 3rd, Hamill RJ, Rodriguez-Barradas MC, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 81: 213-227, 2002. [DOI] [PubMed] [Google Scholar]
  • 15. Shelburne SA, Visnegarwala F, Darcourt J, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 19: 399-406, 2005. [DOI] [PubMed] [Google Scholar]
  • 16. Nakamura H, Kashiwabara K, Fukai Y, Semba H. Clinical evaluation of diagnosis and treatment in three cases of primary pulmonary cryptococcosis. Nihon Kyobu Shikkan Gakkai Zasshi (Jpn J Thorac Dis) 31: 1257-1261, 1993(in Japanese, Abstract in English). [PubMed] [Google Scholar]
  • 17. LaGatta MA, Jordan C, Khan W, Toomey J. Isolated pulmonary cryptococcosis in pregnancy. Obstet Gynecol 92: 682-684, 1998. [DOI] [PubMed] [Google Scholar]
  • 18. Einsiedel L, Gordon DL, Dyer JR. Paradoxical inflammatory reaction during treatment of Cryptococcus neoformans var. gattii meningitis in an HIV-seronegative woman. Clin Infect Dis 39: e78-e82, 2004. [DOI] [PubMed] [Google Scholar]
  • 19. Nakamura S, Izumikawa K, Seki M, et al. Pulmonary cryptococcosis in late pregnancy and review of published literature. Mycopathologia 167: 125-131, 2009. [DOI] [PubMed] [Google Scholar]
  • 20. Asadi Gharabaghi M, Allameh SF. Primary pulmonary cryptococcosis. BMJ Case Rep: 2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Hagan JE, Dias JS, Villasboas-Bisneto JC, Falcão MB, Ko AI, Ribeiro GS. Puerperal brain cryptococcoma in an HIV-negative woman successfully treated with fluconazole: a case report. Rev Soc Bras Med Trop 47: 254-256, 2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Kaplan A, Berntson DG, Ferrieri P. Postpartum cryptococcal pulmonary lesion incidentally discovered during a pulmonary-embolism evaluation of a 28-year-old caucasian woman. Lab Med 46: 69-73, 2015. [DOI] [PubMed] [Google Scholar]
  • 23. Mittal N, Vatsa S, Minz A. Fatal meningitis by Cryptococcus laurentii in a post-partum woman: a manifestation of immune reconstitution inflammatory syndrome. Indian J Med Microbiol 33: 590-593, 2015. [DOI] [PubMed] [Google Scholar]

Articles from Internal Medicine are provided here courtesy of Japanese Society of Internal Medicine

RESOURCES